Addington, J. (1998). Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services, 49(7), 925–928.

Addington, J., el-Guebaly, N., Duchak, V., & Hodgins, D. (1999). Using measures of readiness to change in individuals with schizophrenia. American Journal of Drug & Alcohol Abuse, 25(1), 151–161.

Aguinis, H., Pierce, C. A., & Quigley, B. M. (1995). Enhancing the validity of self-reported alcohol and marijuana consumption using a bogus pipeline procedure: A meta-analytic review. Basic Applied Social Psychology, 16(4), 515–527.

Allebeck, P., & Allgulander, C. (1990). Suicide among young men: psychiatric illness, deviant behaviour and substance abuse. Acta Psychiatrica Scandinavica, 81(6), 565–570.

Appleby, L., Dyson, V., Luchins, D. J., & Cohen, L. S. (1997). The impact of substance use screening on a public psychiatric inpatient population. Psychiatric Services, 48(10), 1311–1316.

Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., Sly, K., Devir, H., & Terry, M. (in press). Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction, 97.

Bandura, A. (1986). Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall.

Barrowclough, C., Haddock, G., Tarrier, N., Lewis, S.W., Moring, J., O'Brien, R., Schofield, N., & McGovern, J. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158(10), 1706–1713.

Bartels, S. J., Teague, G. B., Drake, R. E., Clark, R. E., Bush, P.W., & Noordsy, D. L. (1993). Substance abuse in schizophrenia: service utilization and costs. Journal of Nervous and Mental Disorders, 181(4), 227–232.

Beck, A.T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive Therapy of Depression. New York: Guilford.

Beck, A.T., Ward, C., & Mendelson, M. (1961). An Inventory for measuring depression. Archives of General Psychiatry, 4, 53–63.

Beck, A.T., Wright, F. D., Newman, C. F., & Liese, B. S. (1993). Cognitive Therapy of Substance Abuse. New York: Guilford Press.

Bellack, A. S., & DiClemente, C. C. (1999).Treating substance abuse among patients with schizophrenia. Psychiatric Services, 50(1), 75–80.

Bennett, M. E., Bellack, A. S., & Gearon, J. S. (2001).Treating substance abuse in schizophrenia: An initial report. Journal of Substance Abuse Treatment, 20, 163–175.Top of page

Berkson, J. (1946). Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin, 2, 47–53.

Beusenberg, M., & Orley, J. (1994). The Self-Reporting Questionnaire. Geneva: World Health Organisation.

Birchwood, M., Smith, J., Drury, V., Healy, J., Macmillan, F., & Slade, M. (1994). A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica, 89(1), 62–67.

Blume, A.W., & Marlatt, G. A. (2000). Recent important substance-related losses predict readiness to change scores among people with co-occurring psychiatric disorders. Addictive Behaviours, 25, 461–464.

Blume, A.W., & Schmaling, K. B. (1997). Specific classes of symptoms predict readiness to change scores among dually diagnosed patients. Addictive Behaviours, 22, 625–630.

Blume, A.W., Schmaling, K. B., & Marlatt, G. A. (2001). Motivating drinking behaviour change: Depressive symptoms may not be noxious. Addictive Behaviours, 26, 267–272.

Brady, K.T., Dansky, B. S., Back, S. E., Foa, E. B., & Carroll, K. M. (2001). Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: Preliminary findings. Journal of Substance Abuse Treatment, 21, 47–54.

Brady, K.T., Sonne, S. C., & Roberts, J. M. (1995). Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. Journal of Clinical Psychiatry, 56(11), 502–505.

Brenner, L. M., Karper, L. P., & Krystal, J. H. (1994). Short-term use of disulfiram with clozapine. Journal of Clinical Psychopharmacology, 14, 213–215.

Breslau, N., Kilbey, M. M., & Andreski, P. (1992). Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. American Journal of Psychiatry, 149(4), 464–469.

Brown, P. J., Stout, R. L., & Gannon-Rowley, J. (1998). Substance use disorder-PTSD comorbidity: Patients' perceptions of symptom interplay and treatment issues. Journal of Substance Abuse Treatment, 15(5), 445–448.

Brown, R. A., Evans, D. M., Miller, I.W., Burgess, E. S., & Mueller, T. I. (1997). Cognitive-behavioral treatment for depression in alcoholism. Journal of Consulting & Clinical Psychology, 65(5), 715–726.

Brown, R. A., Monti, P. M., Myers, M. G., Martin, R. A., Rivinus, T., Dubreuil, M. E., & Rohsenow, D. J. (1998). Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. American Journal of Psychiatry, 155(2), 220–225.

Brown, S., Inskip, H., & Barraclough, B. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212–217.Top of page

Brown, S., & Schuckit, M. (1988). Changes in depression amongst abstinent alcoholics. Journal of Studies in Alcohol, 52, 37–43.

Brown, T. A., & Barlow, D. H. (1992). Comorbidity among anxiety disorders: implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychology, 60, 835–844.

Brugha, T. S., Jenkins, R., Taub, N., Meltzer, H., & Bebbington, P. E. (2001). A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychological Medicine, 31(6), 1001–1013.

Brunette, M. F., Drake, R. E., Woods, M., & Hartnett, T. (2001). A comparison of long-term and short-term residential treatment programs for dual diagnosis patients. Psychiatric Services, 52, 526–528.

Buckley, P., Thompson, P., Way, L., & Meltzer, H.Y. (1994). Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry, 151(3), 385–389.

Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders: Findings from the Australian National Survey of Mental Health and Wellbeing. Drug and Alcohol Dependence (in press).

Butzlaff, R. L., & Hooley, J. M. (1998). Expressed emotion and psychiatric relapse. Archives of General Psychiatry, 55, 547–552.

Carey, K. B., Cocco, K. M., & Correia, C. J. (1997). Reliability and validity of the Addiction Severity Index among outpatients with severe mental illness. Psychological Assessment, 9(4), 422–428.

Carey, K. B., Purnine, D. M., Maisto, S. A., & Carey, M. P. (2001). Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention. Behavior Modification, 25(3), 331–384.

Carey, K. B., & Simons, J. (2000). Utility of collateral information in assessing substance use among psychiatric outpatients. Journal of Substance Abuse, 11(2), 139–147.

Carmichael, D., Tackett-Gibson, M., O'Dell, L., Jayaruria, B., Jordan, J., & Menon, R. (1998). The Texas dual diagnosis project evaluation report, 1997–1998. College Station, TX: Public Policy Institute, Texas A&M University.

Casey, D. E. (1999).Tardive dyskinesia and atypical antipsychotic drugs. Schizophrenia Research, 35 (Suppl), S61–66.

Caton, C. L. (1995). Mental health service use among homeless and never-homeless men with schizophrenia. Psychiatric Services, 46(11), 1139–1143.

Caton, C. L., Shrout, P. E., Eagle, P. F., Opler, L. A., & Felix, A. (1994). Correlates of codisorders in homeless and never homeless indigent schizophrenic men. Psychological Medicine, 24(3), 681–688.Top of page

Charney, D. A., Paraherakis, A. M., & Gill, K. J. (2001). Integrated treatment of comorbid depression and substance use disorders. Journal of Clinical Psychiatry, 62(9), 672–677.

Claus, R. E., Mannen, R. K., & Schicht, W. W. (1999).Treatment career snapshots: profiles of first treatment and previous treatment clients. Addictive Behaviors, 24(4), 471–479.

Conley, R. R., Kelly, D. L., & Gale, E. A. (1998). Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophrenia Research, 33(1–2), 95–101.

Cornelius, J. R., Salloum Ihsan, M., Ehler, J. G., & Jarrett, P. J. (1997). Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacology Bulletin, 33(1), 165–170.

Cunningham, J. A., Sobell, L. C., Gavin, D. R., Sobell, M. B., & Breslin, F. C. (1997). Assessing motivation for change: Preliminary development and evaluation of a scale measuring the costs and benefits of changing alcohol or drug use. Psychology of Addictive Behaviors, 11(2), 107–114.

Dalack, G.W., Becks, L., Hill, E., Pomerleau, O. F., & Meador-Woodruff, J. H. (1999). Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology, 21(2), 195–202.

Daley, D. C., Salloum, I. M., Zuckoff, A., Kirisci, L., & Thase, M. E. (1998). Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study. American Journal of Psychiatry, 155(11), 1611–1613.

Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733–742.

Darke, S., Ward, J., Hall, W., Heather, N., & Wodak, A. (1991). The opiate treatment index (oti) manual (Technical Report 11). Sydney, Australia: National Drug and Alcohol Research Centre.

David, A. S. (1990). Insight and psychosis. British Journal of Psychiatry, 156, 798–808.

Dawe, S., Loxton, N. J., Hides, L., Kavanagh, D. J., & Mattick, R. P. (in press). Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders. Canberra: Commonwealth Department of Health and Aged Care.

De Leon, G. (2001). Retention in substance dependence treatment: The relevance of in-treatment factors. Journal of Substance Abuse Treatment, 20(4), 263–264.

De Leon, G., Melnick, G., Kressel, D., & Jainchill, N. (1994). Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. American Journal of Drug & Alcohol Abuse, 20(4), 495–515.

Deas, D., Randall, C. L., Roberts, J. S., & Anton, R. F. (2000). A double-blind, placebocontrolled trial of sertraline in depressed adolescent alcoholics: A pilot study. Human Psychopharmacology, 15(6), 461–469.Top of page

Degenhardt, L., Hall, W., & Lynskey, M. (2001). Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction, 96(11), 1603–1614.

Derogatis, L. R. (1994). Symptom Checklist-90-Revised: Administration, scoring and procedures manual (3 ed.). Minneapolis, MN: National Computer Systems, Inc.

Derogatis, L. R., & Meilisaratos, N. (1983). The Brief Symptom Inventory: An introductory report. Psychological medicine, 13, 595–605.

Dickey, B., Azeni, H., Weiss, R., & Sederer, L. (2000). Schizophrenia, substance use disorders and medical co-morbidity. Journal of Mental Health Policy Economics, 3(1), 27–33.

DiClemente, C. C., & Hughes, S. O. (1990). Stages of change profiles in outpatient alcoholism treatment. Journal of Substance Abuse, 2(2), 217–235.

Dixon, L., Haas, G., Weiden, P., Sweeney, J., & Frances, A. (1991). Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry, 148(2), 224–230.

Dixon, L., McNary, S., & Lehman, A. (1995). Substance abuse and family relationships of persons with severe mental illness. American Journal of Psychiatry, 152, 456–458.

Dixon, L., Weiden, P. J., Haas, G., Sweeney, J., & Frances, A. J. (1992). Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Comprehensive Psychiatry, 33(2), 121–122.

Dorus, W., Ostrow, D. G., Anton, R., Cushman, P., Collins, J. F., Schaefer, M., Charles, H. L., Desai, P., Hayashida, M., & Malkerneker, U. (1989). Lithium treatment of depressed and nondepressed alcoholics. JAMA, 262(12), 1646–1652.

Drake, R., Osher, F., & Wallach, M. (1989). Alcohol use and abuse in schizophrenia. Journal of Nervous and Mental Disease, 177(7), 408–414.

Drake, R. E., Antosca, L. M., Noordsy, D. L., Bartels, S. J., & Osher, F. C. (1991). New Hampshire's specialised services for the dually diagnosed. In K. Minkoff & R. E. Drake (Eds.), New Directions for Mental Health Services (Vol. 50, pp. 57–67). San Francisco: Jossey-Bass.

Drake, R. E., Mercer-McFadden, C., Mueser, K.T., McHugo, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24(4), 589–608.

Drake, R. E., & Wallach, M. A. (1993). Moderate drinking among people with severe mental illness. Hospital & Community Psychiatry, 44(8), 780–782.

Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000). The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bulletin, 26(2), 441–449.

Drake, R. E., Yovetich, N. A., Bebout, R. R., Harris, M., & McHugo, G. J. (1997). Integrated treatment for dually diagnosed homeless adults. Journal of Nervous & Mental Disease, 185(5), 298–305.Top of page

Evins, A. E., & Tisdale, T. (1999). Bupropion and smoking cessation. American Journal of Psychiatry, 156(5), 798–799.

Ewing, J. A. (1984). Detecting alcoholism. The CAGE questionnaire. JAMA, 252(14), 1905–1907.

Feunekes, G. I., van 't Veer, P., van Staveren, W. A., & Kok, F. J. (1999). Alcohol intake assessment: the sober facts. American Journal of Epidemiology, 150(1), 105–112.

Fichter, M. M., Glynn, S. M., Weyerer, S., Liberman, R. P., & Frick, U. (1997). Family climate and expressed emotion in the course of alcoholism. Family Process, 36(2), 202–221.

First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B.W., & Benjamin, I. (1994). Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II).Version 2.0. New York: Biometric Research Department, New York Psychiatric Hospital.

Fleming, M. F., Barry, K. L., Manwell, L. B., Johnson, K., & London, R. (1997). Brief physician advice for problem alcohol drinkers: A randomized controlled trial in community-based primary care practices. JAMA, 277(13), 1039–1045.

Folstein, M. F., Folstein, S. E., & McHugo, P. R. (1975). 'Mini-mental state'. A practical method for grading the cognitive state of the patients for the clinician. Journal of Psychiatric Research, 12, 189–198

Franken, I. H., & Hendriks, V. M. (1999). Predicting outcome of inpatient detoxification of substance abusers. Psychiatric Services, 50(6), 813–817.

Galanter, M., & Castaneda, R. (1988). Substance abuse among general psychiatric patients: Place of presentation, diagnosis, and treatment. American Journal of Drug and Alcohol Abuse, 14(2), 211–235.

George, T. P., & Krystal, J. H. (2000). Comorbidity of psychiatric and substance abuse disorders. Current Opinion in Psychiatry, 13(3), 327–331.

George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S.W. (1995). Effects of clozapine on smoking in chronic schizophrenic outpatients. Journal of Clinical Psychiatry, 56(8), 344–346.

George ,T. P., Ziedonis, D. M., Feingold, A., Pepper, W.T., Satterburg, C. A., Winkel, J., Rounsaville, B. J., & Kosten, T. R. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157(11), 1835–1842.

Godley, S. H., Hoewing-Roberson, R., & Godley, M. D. (1994). Final MISA Report. Bloomington, ILL: Lighthouse Institute.

Goldberg, D., & Williams, P. (1988). A user's guide to the General Health Questionnaire. Windsor: NFER-NELSON Publishing Company.

Goldberg, D. P., Gater, R., Sartorius, N., Ustun, T. B., & et al. (1997). The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine, 27(1), 191–197.

Graham, K., Leonard, K. E., Room, R., Wild, T. C., Pihl, R. O., Bois, C., & Single, E. (1998). Current directions in research on understanding and preventing intoxicated aggression. Addiction, 93(5), 659–676.Top of page

Green, M. F., Marshall, B. D., Jr., Wirshing,W. C., Ames, D., Marder, S. R., McGurk, S., Kern, R. S., & Mintz, J. (1997). Does risperidone improve verbal working memory in treatment-resistant schizophrenia? American Journal of Psychiatry, 154(6), 799–804.

Haddock, G., Barrowclough, C., Tarrier, N., Moring, J., O'Brien, R., Schofield, N., Quinn, J., Palmer, S., Davies, L., Lowens, I., McGovern, J., & Lewis, S. (2002). Motivational interviewing, cognitive behaviour therapy and family intervention for people with schizophrenia and substance misuse problems: Long-term follow-up outcomes. Paper presented at the 30th Anniversary Annual Conference, Warwick, UK.

Hagger, C., Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., & Meltzer, H.Y. (1993). Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry, 34(10), 702–712.

Hasin, D., & Carpenter, K. M. (1998). Difficulties with questions on usual drinking and the measurement of alcohol consumption. Alcoholism: Clinical & Experimental Research, 22(3), 580–584.

Hayward, P., Chan, N., Kemp, R., & Youle, S. (1995). Medication self-management: A preliminary report on an intervention to improve medication compliance. Journal of Mental Health, 4(5), 511–517.

Heather, N., Rollnick, S., & Bell, A. (1993). Predictive validity of the Readiness to Change Questionnaire. Addiction, 88(12), 1667–1677.

Hellerstein, D. J., Rosenthal, R. N., & Miner, C. R. (1995). A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients. American Journal on Addictions, 4(1), 33–42.

Herman, S. E., Frank, K. A., Mowbray, C.T., Ribisl, K. M., Davidson, W. S., 2nd, Boots-Miller, B., Jordan, L., Greenfield, A. L., Loveland, D., & Luke, D. A. (2000). Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. Journal of Behavioral Health Services & Research, 27(3), 286–302.

Hodgkins, D. C., el-Guebaly, N., Armstrong, S., & Dufour, M. (1999). Implications of depression on outcome from alcohol dependence: a three-year prospective follow-up. Alcoholism: Clinical and Experimental Research, 23, 151–157.

Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine, 13(1), 177–183.

Howard, W.T., & Warnock, J. K. (1999). Bupropion-induced psychosis. American Journal of Psychiatry, 156(12), 2017–2018.

Hulse, G. K., & Tait, R. J. (2002). Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug and Alcohol Review, 21, 105–112.

Hunt, G. M., & Azrin, N. H. (1973). A community-reinforcement approach to alcoholism. Behaviour Research & Therapy, 11(1), 91–104.Top of page

Jackson, H. J., & Edwards, J. (1992). Social networks and social supports in schizophrenia: Correlates and assessment. In D. J. Kavanagh (Ed.), Schizophrenia: An overview and practical handbook, (pp. 275–292). London: Chapman & Hall.

Kaskutas, L. A., & Graves, K. (2000). An alternative to standard drinks as a measure of alcohol consumption. Journal of Substance Abuse, 12(1–2), 67–78.

Kavanagh, D. J. (1992). Self-efficacy and depression. In R. Schwartzer (Ed.), Self-efficacy: Thought control of action (pp. 177–193). New York: Hemisphere.

Kavanagh, D. J., Greenaway, L., Jenner, L., Saunders, J. B., White, A., Sorban, J., & Hamilton, G. (2000). Contrasting views and experiences of health professionals on the management of comorbid substance misuse and mental disorders. Australian & New Zealand Journal of Psychiatry, 34(2), 279–289.

Kavanagh, D. J., Saunders, J. B., Young, R., White, A., Jenner, L., Clair, A., & Wallis, J. (1999). Evaluation of screening and brief intervention for substance abuse in early psychosis. A report to AUSEINET. Brisbane: Department of Psychiatry, University of Queensland.

Kavanagh, D. J., Sitharthan, T., Spilsbury, G., & Vignaendra, S. (1999). An evaluation of brief correspondence programs for problem drinkers. Behavior Therapy, 30, 641–656.

Kavanagh, D. J., White, A., Young, R., & Jenner, L. (2000).Towards an integrated and sensitive family intervention for comorbid substance abuse and schizophrenia: A comment on Shiels and Rolfe (2000). Australian Journal of Family Therapy, 21, 88–90.

Kavanagh, D. J., Young, R., Boyce, L., Clair, A., Sitharthan, T., Clark, D., & Thompson, K. (1998). Substance Treatment Options in Psychosis (STOP): A new intervention for dual diagnosis. Journal of Mental Health, 7(2), 135–143.

Kavanagh, D. J., Young, R., Saunders, J. B., White, A., Shockley, N., Jenner, L., Clair, A., & Wallis, J. (in submission). Start Over and Survive (SOS): Preliminary trial of a brief intervention for substance abuse in psychosis.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276.

Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: randomised controlled trial. BMJ, 312, 346–349.

Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry, 172, 413–419.

King, T. K., & DiClemente, C. C. (1993). A decisional balance measure for assessing and predicting drinking behaviour. Unpublished manuscript.

Klerman, G. L., Weissman, M. M., Rounsaville, B. J., & Chevron, E. S. (1984). Interpersonal psychotherapy of depression. New York: Basic Books.

Kobak, K. A., Taylor, L. H., Dottl, S. L., Greist, J. H., Jefferson, J.W., Burroughs, D., Mantle, J. M., Katzelnick, D. J., Norton, R., Henk, H. J., & Serlin, R. C. (1997). A computer-administered telephone interview to identify mental disorders. JAMA, 278(11), 905–910.Top of page

Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J., & Bohn, M. J. (1994). Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Archives of General Psychiatry, 51(9), 720–731.

Kranzler, H. R., Burleson, J. A., Korner, P., Del Boca, F. K., Bohn, M. J., Brown, J., & Liebowitz, N. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry, 152(3), 391–397.

Kranzler, H. R., & Van Kirk, J. (2001). Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical & Experimental Research, 25(9), 1335–1341.

Kurtz, L., Garvin, C., Hill, E., Pollio, D., McPherson, S., & Powell, T. (1995). Involvement in Alcoholics Anonymous by persons with dual disorders. Alcoholism Treatment Quarterly, 12, 1–17.

Larson, E., Olincy, A., Rummans, T. A., & Morse, R. M. (1992). Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: A review. Alcoholism: Clinical and Experimental Research, 16(1), 125–130.

Lehman, A. F., Myers, C. P., Thompson, J.W., & Corty, E. (1993). Implications of mental and substance use disorders: A comparison of single and dual diagnosis patients. Journal of Nervous & Mental Disease, 181(6), 365–370.

Lehman, C. L., Brown, T. A., & Barlow, D. H. (1998). Effects of cognitive-behavioral treatment for panic disorder with agoraphobia on concurrent alcohol abuse. Behavior Therapy, 29(3), 423–433.

Lennox, R. D., Scott-Lennox, J. A., & Bohlig, E. M. (1993). The cost of depression-complicated alcoholism: health-care utilization and treatment effectiveness. Journal of Mental Health Administration, 20(2), 138–152.

Levin, F. R., Evans, S. M., Coomaraswammy, S., Collins, E. D., Regent, N., & Kleber, H. D. (1998). Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. American Journal of Drug & Alcohol Abuse, 24(3), 343–360.

Levinson, I., Galynker, I., & Rosenthal, R. N. (1995). Methadone withdrawal psychosis. Journal of Clinical Psychiatry, 56(2), 73–76.

Ley, A., Jeffrey, D. P., McLaren, S., & Siegfried, N. (Eds.). (2001). Treatment programmes for people with both severe mental illness and substance misuse. Oxford: Update Software.

Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lonnqvist, J. (2001). Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry, 58(6), 573–578.

Littrell, K. H., Petty, R. G., Hilligoss, N. M., Peabody, C. D., & Johnson, C. G. (2001). Olanzapine treatment for patients with schizophrenia and substance abuse. Journal of Substance Abuse Treatment, 21(4), 217–221.Top of page

Lukoff, D., Liberman, R. P., & Nuechterlein, K. H. (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12(4), 578–602.

Maisto, S. A., Carey, M. P., Carey, K. B., Gordon, C. M., & Gleason, J. R. (2000). Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychological Assessment, 12(2), 186–192.

Malcolm, R., Anton, R. F., Randall, C. L., & Johnston, A. (1992). A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical & Experimental Research, 16(6), 1007–1013.

Malcolm, R., O'Neil, P. M., Von, J. M., & Dickerson, P. C. (1987). Naltrexone and dysphoria: a double-blind placebo controlled trial. Biological Psychiatry, 22(6), 710–716.

Marcus, P., & Snyder, R. (1995). Reduction of comorbid substance abuse with clozapine. American Journal of Psychiatry, 152(6), 959.

Mason, B. J., Kocsis, J. H., Melia, D., Khuri, E.T., Sweeney, J., Wells, A., Borg, L., Millman, R. B., & Kreek, M. J. (1998). Psychiatric comorbidity in methadone maintained patients. Journal of Addictive Diseases, 17(3), 75–89.

Mason, B. J., Kocsis, J. H., Ritvo, E. C., & Cutler, R. B. (1996). A double-blind, placebocontrolled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA, 275(10), 761–767.

Mattick, R. P., & Jarvis, T. (Eds.). (1993). An outline for the management of alcohol problems: Quality assurance project. Canberra: Australian Government Publishing Service.

Maxwell, S., & Shinderman, M. S. (2000). Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. Journal of Addictive Diseases, 19(3), 61–69.

McConnaughy, E. A., Prochaska, J. O., & Velicer, W. F. (1983). Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research & Practice, 20(3), 368–375.

McEvoy, J., & Brown, S. (1999). Smoking in first-episode patients with schizophrenia. American Journal of Psychiatry, 156, 1120A–1121.

McGrath, J., & Emmerson, W. B. (1999). Fortnightly review.Treatment of schizophrenia. BMJ, 319(7216), 1045–1048.

McGrath, P. J., Nunes, E.V., Stewart, J.W., Goldman, D., Agosti, V., Ocepek-Welikson, K., & Quitkin, F. M. (1996). Imipramine treatment of alcoholics with primary depression. Archives of General Psychiatry, 53, 232–240.

McHugo, G. J., Drake, R. E., Burton, H. L., & Ackerson,T. H. (1995). A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease, 183(12), 762–767.Top of page

McKenna, G. J. (1982). Methadone and opiate drugs: psychotropic effect and self-medication. Annals of the New York Academy of Science, 398, 44–55.

McLellan, A., Luborsky, L., Woody, G., & O'Brien, C. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26–33.

McPhillips, M. A., Kelly, F. J., Barnes, T. R. E., Duke, P. J., Gene-Cos, N., & Clark, K. (1997). Detecting comorbid substance misuse among people with schizophrenia in the community: A study comparing the results of questionnaires with analysis of hair and urine. Schizophrenia Research, 25(2), 141–148.

Meissen, G., Powell, T. J., Wituk, S. A., Girrens, K., & Arteaga, S. (1999). Attitudes of AA contact persons toward group participation by persons with a mental illness. Psychiatric Services, 50, 1079–1081.

Miller, W. J., & Rollnick, S. (2002). Motivational interviewing: preparing people for change (2 ed.). New York, NY: Guilford Press.

Miller, W. R., & Tonigan, J. S. (1996). Assessing drinkers' motivations for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). Psychology of Addictive Behaviors, 10(2), 81–89.

Miller, W. R., & Wilbourne, P. L. (2002). Mesa Grande: A methodological analysis of clinical trials of treatment for alcohol use disorders. Addiction, 97(3), 265–277.

Minkoff, K. (1989). An integrated treatment model for dual diagnosis of psychosis and addiction. Hospital and Community Psychiatry, 40(10), 1031–1036.

Miotto, K., McCann, M., Basch, J., Rawson, R., & Ling, W. (2002). Naltrexone and dysphoria: fact or myth? American Journal on Addictions, 11(2), 151–160.

Monti, P. M., Colby, S. M., Barnett, N. P., Spirito, A., Rohsenow, D. J., Myers, M., Woolard, R., & Lewander, W. (1999). Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. Journal of Consulting & Clinical Psychology, 67(6), 989–994.

Moyer, A., Finney, J.W., Swearingen, C. E., & Vergun, P. (2002). Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction, 97(3), 279–292.

Mueser, K., Bellack, A., & Blanchard, J. (1992). Comorbiditiy of schizophrenia and substance abuse: Implications for treatment. Journal of Consulting and Clinical Psychology, 60(6), 845–856.

Mueser, K.T., Drake, R. E., & Noordsy, D. L. (1998). Integrated mental health and substance abuse treatment for severe mental disorders. Journal of Practical Psychiatry and Behavioral Health, 4, 129–139.

Mueser, K.T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors, 23(6), 717–734.

Mueser, K.T., & Fox, L. (2002). A family intervention program for dual disorders. Community Mental Health Journal, 38, 253–270.Top of page

Mueser, K.T., Noordsy, D. L., Fox, L., & Wolfe, R. (2000). Disulfiram treatment for alcoholism in severe mental illness. American Journal on Addictions.

Mueser, K.T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morrison, R. L., & Yadalam, K. G. (1990). Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin, 16, 31–56.

Mueser, T., Noordsy, D. L., Fox, L., & Wolfe, R. (in press). Disulfiram treatment for alcoholism in severe mental illness. American Journal on Addictions.

Nisbett, R., & Ross, L. (1980). Human inference: Strategies and shortcomings of human social judgement. Englewood Cliffs, NJ: Prentice-Hall.

Noordsy, D. L., Schwab, B., Fox, L., & Drake, R. E. (1996). The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders. Community Mental Health Journal, 32(1), 71–81.

Oei,T. P. S., & Loveday, W. A. L. (1997). Lifetime diagnosis of major depression as a multivariate predictor of treatment outcome for patients with substance abuse. Drug and Alcohol Review, 16, 261–274.

Olivera, A. A., Kiefer, M.W., & Manley, N. K. (1990).Tardive dyskenesia in psychiatric patients with substance use disorders. American Journal of Drug and Alcohol Abuse, 16, 57–66.

Omrod, J., & Budd, R. (1991). A comparison of two treatment interventions aimed at lowering anxiety levels and alcohol consumption among alcohol abusers. Drug and Alcohol Dependence, 27, 233–243.

Osher, F. C., & Kofoed, L. L. (1989).Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry, 40(10), 1025–1030.

Overall, J., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799–812.

Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services, 47(8), 853–858.

Perrone, J., De Roos, F., Jayaraman, S., & Hollander, J. E. (2001). Drug screening versus history in detection of substance use in ED psychiatric patients. American Journal of Emergency Medicine, 19(1), 49–51.

Peters, L., & Andrews, G. (1995). Procedural validity of the computerized version of the Composite International Diagnostic Interview (CIDI-Auto) in the anxiety disorders. Psychological Medicine, 25(6), 1269–1280.

Peters, L., Clarke, D., & Carroll, F. (1999). Are computerised interviews equivalent to human interviewers? CIDI-Auto versus CIDI in Anxiety and Depressive Disorders. Psychological Medicine, 28, 893–901.

Petrakis, I., Carroll, K. M., Nich, C., Gordon, L., Kosten, T., & Rounsaville, B. (1998). Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug & Alcohol Dependence, 50(3), 221–226.Top of page

Polcin, D. L. (1992). Issues in the treatment of dual diagnosis clients who have chronic mental illness. Professional Psychology Research & Practice, 23(1), 30–37.

Poulsen, H. E., Loft, S., Andersen, J. R., & Andersen, M. (1992). Disulfiram therapy: Adverse drug reactions and interactions. Acta Psychiatrica Scandinavica, 86(Suppl 369), 59–66.

Primm, A. B., Gomez, M. B., Tzolova-Iontchev, I., Perry, W., Vu, H.T., & Crum, R. M. (2000). Mental health versus substance abuse treatment programs for dually diagnosed patients. Journal of Substance Abuse Treatment, 19(3), 285–290.

Prochaska, J., & DiClemente, C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390–395.

Prochaska, J. O., & DiClemente, C. C. (1986).Toward a comprehensive model of change. In W. R. Miller & N. Heather (Eds.), Treating Addictive Behaviors (2 ed., pp. 3–27). New York & London: Plenum Press.

Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change. Applications to addictive behaviors. American Psychologist, 47(9), 1102–1114.

Project MATCH Research Team. (1997). Matching alcoholism treatments to client heterogeneity: Project MATCH Post-treatment drinking outcomes. Journal of Studies on Alcohol, 58(1), 7–29.

Randall, C. L., Thomas, S., & Thevos, A. K. (2001). Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcoholism: Clinical & Experimental Research, 25(2), 210–220.

Rankin, H. (1990).Validity of self-reports in clinical settings. Behavioral Assessment, 12(1), 107–116.

Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511–2518.

Reichler, D., Baker, A., Lewin, T., & Carr, V. (2001). Smoking among inpatients with drug related problems in an Australian psychiatric hospital. Drug and Alcohol Review, 20, 231–237.

Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990). Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophrenia Bulletin, 16(1), 123–132.

Rogers, E. S., Martin, R., Anthony, W., Massaro, J., Danley, K., Crean, T., & Penk, W. (2001). Assessing readiness for change among persons with severe mental illness. Community Mental Health Journal, 37(2), 97–112.

Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87(5), 743–754.

Rollnick, S., Mason, P., & Butler, C. (1999). Health behaviour change: A guide for practitioners. New York: Churchill Livingstone.Top of page

Rollnick, S., & Miller, W. R. (1995).What is motivational interviewing? Behavioural & Cognitive Psychotherapy, 23(4), 325–334.

Rosenberg, S. D., Drake, R. E., Wolford, G. L., Mueser, K.T., Oxman, T. E., Vidaver, R. M., Carrieri, K. L., & Luckoor, R. (1998). Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. American Journal of Psychiatry, 155(2), 232–238.

Rosenheck, R., Tekell, J., Peters, J., Cramer, J., Fontana, A., Xu, W., Thomas, J., Henderson, W., & Charney, D. (1998). Does participation in psychosocial treatment augment the benefit of clozapine? Archives of General Psychiatry, 55, 618–625.

Rosenthal, R. N., Hellerstein, D. J., & Miner, C. R. (1992). A model of integrated services for outpatient treatment of patients with comorbid schizophrenia and addictive disorders. American Journal on Addictions, 1(4), 339–348.

Roy, A. (1998). Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry, 44(7), 633–637.

Roy-Byrne, P. P., Pages, K. P., Russo, J. E., Jaffe, C., Blume, A.W., Kingsley, E., Cowley, D. S., & Ries, R. K. (2000). Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 20(2), 129–136.

Salloum, I. M., Cornelius, J. R., Thase, M. E., Daley, D. C., Kirisci, L., & Spotts, C. (1998). Naltrexone utility in depressed alcoholics. Psychopharmacology Bulletin, 34(1), 111–115.

Salyers, M. P., & Mueser, K.T. (2001). Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research, 48(1), 109–123.

Saunders, B., & Robinson, S. (in press). Co-occurring mental health and drug dependency disorders: Workforce development challenges for the A&D field. Drug and Alcohol Review.

Saunders, J. B., Aasland, O. G., Babor, T. F., Fuente, J. R. d. l., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT):WHO collaborative project on early detection of persons with harmful alcohol consumption — II. Addiction, 88, 791–804.

Schmitz, J. M., Averill, P., Stotts, A. L., Moeller, F. G., Rhoades, H. M., & Grabowski, J. (2001). Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug & Alcohol Dependence, 63(3), 207–214

Schuckit, M. A. (2000). Drug and alcohol abuse: A clinical guide to diagnosis and treatment (5th ed.). New York, NY, US: Kluwer Academic/Plenum Publishers.

Scott, J., Gilvarry, E., & Farrell, M. (1998). Managing anxiety and depression in alcohol and drug dependence. Addictive Behaviors, 23(6), 919–931.

Scurlock, H., & Lucas, P. (1996). Another case of nicotine psychosis? [letter; comment]. Addiction, 91(9), 1388.

Seinen, A., Dawe, S., Kavanagh, D. J., & Bahr, M. (2000). An examination of the utility of the AUDIT in people diagnosed with schizophrenia. Journal of Studies on Alcohol, 61, 744–750.

Sellman, J. D., & Joyce, P. R. (1996). Does depression predict relapse in the 6 months following treatment for men with alcohol dependence? Australian & New Zealand Journal of Psychiatry, 30(5), 573–578.Top of page

Selzer, M. L. (1971). The Michigan alcoholism screening test: The quest for a new diagnostic instrument. American Journal of Psychiatry, 127, 85–94.

Semler, G., Wittchen, H. U., Joschke, K., Zaudig, M., von Geiso, T., Kaiser, S., von Cranach, M., & Pfister, H. (1987).Test-retest reliability of a standardized psychiatric interview (DIS/CIDI). European Archives of Psychiatry & Neurological Sciences, 236(4), 214–222.

Shiffman, S., Hufford, M., Hickcox, M., Paty, J. A., Gnys, M., & Kassel, J. D. (1997). Remember that? A comparison of real-time versus retrospective recall of smoking lapses. Journal of Consulting & Clinical Psychology, 65(2), 292–300.

Smyth, N. J. (1996). Motivating persons with dual disorders: A stage approach. Families in Society, 77(10), 605–614.

Sobell, L. C., & Sobell, M. B. (1995). Alcohol timeline followback users' manual. Toronto: Addiction Research Foundation.

Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry, 49(8), 624–629.

Spitzer, R. L., Williams, J. B., Kroenke, K., Linzer, M., deGruy, F.V., 3rd, Hahn, S. R., Brody, D., & Johnson, J. G. (1994). Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. Jama., 272(22), 1749–1756.

Sprenger, D. (1997). Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence. Journal of Clinical Psychopharmacology, 17(5), 425–426.

Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2001).Treatment for amphetamine psychosis. Cochrane Database of Systematic Reviews, 4 CD003021.

Stanton, M. D., & Shadish, W. R. (1997). Outcome, attrition, and family-couples treatment for drug abuse: A meta-analysis and review of the controlled, comparative studies. Psychological Bulletin, 122, 170–191.

Steele, C. (2000). Zyban: an effective treatment for nicotine addiction. Hospital Medicine (London). 61(11), 785–788.

Swanson, A. J., Pantalon, M.V., & Cohen, K. R. (1999). Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous & Mental Disease, 187(10), 630–635.

Teesson, M., Clement, N., Copeland, J., Conroy, A., & Reid, A. (2000). The measurement of outcome in alcohol and other drug treatment: A review of available instruments. Sydney: NDARC Technical Report No 92.

Teesson, M., Gallagher, J., & Ozols, S. (1997). The Gemini Project: An integrated treatment approach for persons with serious mental illness and substance misuse. Sydney: South Eastern Sydney Area Health Service.Top of page

Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241–247.

Tollefson, G. D., Lancaster, S. P., & Montague-Clouse, J. (1991). The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. Psychopharmacology Bulletin, 27(2), 163–170.

Tollefson, G. D., Montague-Clouse, J., & Tollefson, S. L. (1992).Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Journal of Clinical Psychopharmacology, 12(1), 19–26.

Townshend, J. M., & Duka, T. (2002). Patterns of alcohol drinking in a population of young social drinkers: a comparison of questionnaire and diary measures. Alcohol & Alcoholism, 37(2), 187–192.

Triffleman, E., Carroll, K., & Kellogg, S. (1999). Substance Dependence posttraumatic stress disorder therapy. Journal of Substance Abuse Treatment, 17, 3–14.

Turner, R.W., & Wehl, C. K. (1984).Treatment of unipolar depression in problem drinkers. Advances in Behaviour Research & Therapy, 6(2), 115–125.

US Department of Health and Human Services. (1994). National trends in smoking cessation, and in the health benefits of smoking cessation. Washington: US Government Printing Office.

Van Horn, D. H. A., & Bux, D. A. J. (2001). A pilot test of motivational interviewing groups for dually diagnosed patients. Journal of Substance Abuse Treatment, 20, 191–195.

Velasquez, M. M., Carbonari, J. P., & DiClemente, C. C. (1999). Psychiatric severity and behavior change in alcoholism: the relation of the transtheoretical model variables to psychiatric distress in dually diagnosed patients. Addictive Behaviors, 24(4), 481–496.

Ventura, J., Green, M. F., Shaner, A., & Liberman, R. P. (1993).Training and quality assurance with the Brief Psychiatric Rating Scale: "The drift busters." International Journal of Methods in Psychiatric Research, 3(4), 221–244.

Verebey, K., Volavka, J., & Clouet, D. (1978). Endorphins in psychiatry: An overview and a hypothesis. Archives of General Psychiatry, 35(7), 877–888.

Voruganti, L. N. P., Heslegrave, R. J., & Awad, A. G. (1997). Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. Journal of Nervous & Mental Disease, 185(7), 463–465.

Warner, R., Taylor, D., Wright, J., Sloat, A., Springett, G., Arnold, S., & Weinberg, H. (1994). Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. American Journal of Orthopsychiatry, 64(1), 30–39.

Weaver, T., Rutter, D., Madden, P., Ward, J., Stimson, G., & Renton, A. (2001). Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: Prevalence and service needs in an inner London borough. Social Psychiatry and Psychiatric Epidemiology, 36, 399–406.Top of page

Weiner, E., Ball, M. P., Summerfelt, A., Gold, J., & Buchanan, R.W. (2001). Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. American Journal of Psychiatry, 158(4), 635–637.

Wetzler, S., & Sanderson, W. C. (1997).Treatment strategies for patients with psychiatric comorbidity. New York, NY, US: John Wiley & Sons, Inc.

Wilk, A. I., Jensen, N. M., & Havighurst, T. C. (1997). Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. Journal of General Internal Medicine, 12(5), 274–283.

Wing, J. K., Babor, T., Brugha, T. B., J., Cooper, J. E., Giel, R., Jablensky, A., Regier, D., & Sartorius, N. (1990). SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry, 47, 589–593.

Woerner, M. G., Mannuzza, S., & Kane, J. M. (1988). Anchoring the BPRS: an aid to improved reliability. Psychopharmacology Bulletin, 24(1), 112–117.

Wolford, G. L., Rosenberg, S. D., Drake, R. E., Mueser, K.T., Oxman, T. E., Hoffman, D., Vidaver, R. M., Luckoor, R., & Carrieri, K. L. (1999). Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychology of Addictive Behaviors, 13(4), 313–326.

Woody, G. E., McLellan, A.T., Luborsky, L., & O'Brien, C. P. (1987).Twelve-month follow-up of psychotherapy for opiate dependence. American Journal of Psychiatry, 144(5), 590–596.

Woody, G. E., McLellan, A.T., Luborsky, L., O'Brien, C. P., Blaine, J., Fox, S., Herman, I., & Beck, A.T. (1984). Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: The Veterans Administration-Penn study. American Journal of Psychiatry, 141, 1172–1177.

Worthington, J., Fava, M., Agustin, C., Alpert, J., Nierenberg, A. A., Pava, J. A., & Rosenbaum, J. F. (1996). Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Psychosomatics, 37, 518–522.

Yassa, R., Lal, S., Korpassy, A., & Ally, J. (1987). Nicotine exposure and tardive dyskinesia. Biological Psychiatry, 22(1), 67–72.

Zanis, D. A., McLellan, A.T., & Corse, S. (1997). Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Mental Health Journal, 33(3), 213–227.

Zaretsky, A., Rector, N. A., Seeman, M.V., & Fornazzari, X. (1993). Current cannabis use and tardive dyskinesia. Schizophrenia Research, 11(1), 3–8.

Ziedonis, D. M., & George, T. P. (1997). Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23(2), 247–254.

Ziedonis, D. M., & Trudeau, K. (1997). Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophrenia Bulletin, 23(2), 229–238.Top of page

Zimmerman, M., & Mattia, J. I. (2001). The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Comprehensive Psychiatry, 42, 175–189.

Zimmerman, M., & Mattia, J. I. (2001). A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry, 58, 787–794.

Zimmet, S.V., Strous, R. D., Burgess, E. S., Kohnstamm, S., & Green, A. I. (2000). Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of Clinical Psychopharmacology, 20(1), 94–98.